The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Transaction in Own Shares

29 Sep 2020 07:00

RNS Number : 3492A
NB Distressed Debt Invest. Fd. Ltd
29 September 2020
 

29 September 2020

 

 

NB Distressed Debt Investment Fund Limited

(the "Company")

 

 

Transaction in Own Shares

 

 

The Company announces that pursuant to the general authority granted by shareholders of the Company on 25 June 2020 to make market purchases of its own New Global ordinary share capital ("New Global Shares") and of its own Extended Life ordinary share capital ("Extended Life Shares"), it repurchased 20,000 New Global Shares at a price of 48 pence per New Global Share, to be cancelled, on 28 September 2020. The Company also repurchased 20,000 Extended Life Shares at a price of $0.41 per Extended Life Share, to be cancelled, on 28 September 2020. This represents approximately 0.0478 per cent of the Company's current issued New Global Shares and approximately 0.0248 per cent of the Company's current issued Extended Life Shares.

 

Following this transaction, the Company has 41,796,617 New Global Shares in issue and 80,730,074 Extended Life Shares in issue. The Company also has 15,382,770 Ordinary Shares in issue. All shares have 1 vote per share.

 

For reporting purposes under the FCA's Disclosure Guidance and Transparency Rules the market should use the figure of 137,909,461 total voting rights when determining if they are required to notify their interest in, or a change to their interest in the Company.

 

 

LEI: YRFO7WKOU3V511VFX790

 

 

Enquiries:

 

Carey

Tom Lancaster-King

Tel: +44 (0) 1481 737 208

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSEEFIAESSEIU

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.